Juravinski Research Institute
Skip to content
Main Menu
Home
About the Institute
Research Projects
In the News
Publications
Donate
Home
In the News
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms
Posted on May 31, 2021
Share
Twitter
Facebook
LinkedIn
Read more at
The Conversation
.
In the News